ZZ Biotech LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2006-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.zzbiotech.com
Clinical Trials
3
Active:0
Completed:2
Trial Phases
3 Phases
Phase 1:1
Phase 2:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (33.3%)Phase 2
1 (33.3%)Phase 3
1 (33.3%)Efficacy and Safety Evaluation of 3K3A-APC in Ischemic Stroke
- First Posted Date
- 2022-08-02
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- ZZ Biotech, LLC
- Target Recruit Count
- 1400
- Registration Number
- NCT05484154
Safety Evaluation of 3K3A-APC in Ischemic Stroke
Phase 2
Completed
- Conditions
- Ischemic Stroke
- Interventions
- Biological: 3K3A-APCDrug: Placebo
- First Posted Date
- 2014-08-21
- Last Posted Date
- 2018-11-08
- Lead Sponsor
- ZZ Biotech, LLC
- Target Recruit Count
- 110
- Registration Number
- NCT02222714
- Locations
- 🇺🇸
Stroke Center, Charlottesville, Virginia, United States
Safety and Pharmacokinetics of Single and Multiple Ascending Doses of 3K3A-APC in Healthy Adult Volunteers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Biological: 3K3A-APC, diluted in 0.9% sodium chloride in waterDrug: 0.9% NaCl in water
- First Posted Date
- 2012-08-08
- Last Posted Date
- 2018-02-05
- Lead Sponsor
- ZZ Biotech, LLC
- Target Recruit Count
- 64
- Registration Number
- NCT01660230
- Locations
- 🇦🇹
Privatklinik Leech, Graz, Austria
News
No news found